SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-021952
Filing Date
2024-02-01
Accepted
2024-02-01 17:24:26
Documents
2
Group Members
SUMITOMO PHARMA CO., LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d724028dsc13ga.htm SC 13G/A 50240
2 EX-99.1 d724028dex991.htm EX-99.1 3856
  Complete submission text file 0001193125-24-021952.txt   55739
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Subject) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-93291 | Film No.: 24587986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020
Business Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020 813-5201-0222
Sumitomo Chemical Co., Ltd. (Filed by) CIK: 0001798550 (see all company filings)

IRS No.: 980339148 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G/A